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ABSTRACT
To date, many anticancer drugs have been developed by directly
or indirectly targeting microtubules, which are involved in cell
division. Although this approach has yielded many anticancer
drugs, these drugs produce undesirable side effects. An
alternative strategy is needed, and targeting mitotic exit may be
one alternative approach. Localization of phosphorylated barrier-
to-autointegration factor (BAF) to the chromosomal core region is
essential for nuclear envelope compartment relocalization. In this
study, we isolated brazilin from Caesalpinia sappan Leguminosae
and demonstrated that it inhibited BAF phosphorylation in vitro
and in vivo. Moreover, we demonstrated direct binding between
brazilin and BAF. The inhibition of BAF phosphorylation induced
abnormal nuclear envelope reassembly and cell death, indicating
that perturbation of nuclear envelope reassembly could be a novel
approach to anticancer therapy. We propose that brazilin isolated
from C. sappan may be a new anticancer drug candidate that
induces cell death by inhibiting vaccinia-related kinase 1–mediated
BAF phosphorylation.
Introduction
Drugs that depolymerize and stabilize microtubules, in-
cluding vinca alkaloids (vinblastine and vincristine) and
taxanes (paclitaxel/taxol and docetaxel), have long been used
to treat cancer (Jordan and Wilson, 2004; Dumontet and
Jordan, 2010). In addition to their anticancer effects, however,
these drugs cause various side effects. To avoid this problem,
researchers have attempted to develop drugs that indirectly
target microtubules via microtubule regulator proteins, such
as polo-like kinase 1 (Plk1), Aurora A and B, and Eg5 (Blangy
et al., 1995; Carmena and Earnshaw, 2003; Barr et al., 2004).
However, some cancer cells that are treated with these drugs
skip mitotic arrest and survive as a result of adaptation or
mitotic slippage in which the spindle assembly checkpoint
does not activate cell cycle arrest after chromosomal segrega-
tion, resulting in the maintenance of aneuploidy (Rieder and
Maiato, 2004; Brito and Rieder, 2006). Thus, rather than
targeting spindle assembly, an alternative strategy of target-
ing mitotic exit has been proposed (Manchado et al., 2012). In
contrast to strategies that rely on microtubule disruption,
directly targeting mitotic exit does not promote adaptation or
mitotic slippage. Therefore, if cancer cells are damaged at
mitotic exit, they cannot escape death. To date, however,
drugs that target mitotic exit have not been commonly used.
To complete mitotic exit, nuclear membrane reformation
and cytokinesis must take place. Nuclear envelope reassem-
bly is a phenomenon in which the nuclear membrane and
associated proteins, such as barrier-to-autointegration factor
(BAF), LEM-domain proteins (LAP2, emerin, and MAN1),
lamin, and nuclear pore complex, relocate around separated
chromosomes during telophase (Haraguchi et al., 2001;
Dechat et al., 2004). BAF is the first of the nuclear
membrane–associated proteins to be recruited to the core
region, the central region of the assembling nuclear rim near
spindle microtubules during nuclear envelope reformation
(Haraguchi et al., 2008). Relocalization of BAF into the core
region of chromosomes leads to recruitment of other nuclear
membrane–anchored proteins and nuclear envelope trans-
membrane proteins. Therefore, BAF is key in controlling the
escape of dividing cells from mitotic exit. Phosphorylated
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residues of vaccinia-related kinase 1 (VRK1), a unique
upstream kinase of BAF, are involved in the dissociation of
chromosomes from the nuclear envelope at mitosis onset and
nuclear envelope reformation at the end of mitosis (Nichols
et al., 2006; Haraguchi et al., 2008). InCaenorhabditis elegans
embryos, depletion of the VRK1 homolog abolishes targeting
of the BAF-1 homolog to the core-like region and prevents
nuclear envelope reformation (Gorjanacz et al., 2007). Indeed,
BAF phosphorylation by VRK1 is required for nuclear
envelope reassembly, although the process is so complex that
the detailed molecular mechanism remains elusive.
We hypothesized that inhibition of VRK1-mediated BAF
phosphorylation might trigger severe cell cycle defects
because BAF phosphorylation is essential for nuclear enve-
lope reassembly. To identify novel inhibitors of BAF phos-
phorylation, we screened a natural herb library. To date,
natural products have been used to develop new treatments
for many diseases. Plants contain a variety of metabolites for
defense, communication, and predation, some of which have
anticancer effects (Cragg et al., 2009). As a result, more than
70% of commercial anticancer drugs have been derived from
or inspired by natural products (Gordaliza, 2007; Cragg et al.,
2009).
Our screen revealed that Caesalpinia sappan extract
inhibited VRK1-mediated BAF phosphorylation. Subse-
quently, brazilin was isolated from the extract as a BAF
inhibitor. C. sappan heartwood has been used as a traditional
medicine for various diseases. Brazilin, one of the main
C. sappan components (Puchtler et al., 1986), is reported to
possess various biologic effects, including anti-inflammatory
activity (Hikino et al., 1977; Bae et al., 2005), antihepatotox-
icity activity (Moon et al., 1992), induction of immunologic
tolerance (Choi and Moon, 1997; Mok et al., 1998), inhibition
of downstream cAMP signaling (Won et al., 2004), inhibition
of protein kinase C and insulin receptor kinase (Kim et al.,
1998), and antiplatelet activity (Hwang et al., 1998). Indeed,
its cytotoxic properties as an antitumor agent have previously
been reported (Kim et al., 2012). However, the detailed
molecular mechanisms underlying these properties are
unclear.
In this study, we isolated brazilin from C. sappan after
screening a natural herb library for inhibitors of VRK1-
mediated BAF phosphorylation. We found that (1) brazilin
inhibited BAF phosphorylation by VRK1 in vitro and in vivo
and (2) the abrogation of BAF phosphorylation is the result of
direct binding between BAF and brazilin. Brazilin-mediated
inhibition of BAF phosphorylation triggers a defect in nuclear
envelope reassembly at the onset of telophase, eventually
resulting in cell death. The anticancer effect of brazilin was
also validated in vivo. On the basis of these results, we
propose that brazilin should be considered a candidate for
a new class of anticancer drugs that target mitotic exit.
Materials and Methods
General Experimental Procedures
Optical rotation was measured using a JASCO P-1020 polarimeter
(Jasco Analytical Instruments, Easton, MD). The infrared (IR)
spectrum was obtained with a Spectrum GX FT-IR spectrometer
(PerkinElmer Life and Analytical Sciences, Waltham, MA). Electron
ionization–magnetic spectrometry (MS) spectra were obtained with
an Agilent 7890A-5975C GC/MSD system (Agilent Technologies,
Santa Clara, CA). The [1H]NMR, [13C]NMR, distortionless enhance-
ment by polarization transfer, correlation spectroscopy, heteronuclear
multiple-bond correlation, and heteronuclear multiple-quantum corre-
lation NMR spectra were obtained with a Bruker DRX-500 Fourier
transform-NMR spectrometer (Bruker Corporation, Bruker, Billerica,
MA). The internal standard, methanol-d4 with trimethoxysilane, was
purchased from Sigma-Aldrich (St. Louis, MO). Merck silica gel 60
(63–200 mm) was used for column chromatography. Analytical thin-
layer chromatography was performed using Merck silica gel 60 F-254
and silica gel 60 RP-18 F-254 thin-layer chromatography plates. Spots
were detected by UV light (254 and 365 nm) and by spraying with 10%
H2SO4 and heating on a hot plate.
Reagents
Lamin B, glyceraldehyde 3-phosphate dehydrogenase, and gluta-
thione S-transferase antibody were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA) and histone H3 phospho-Ser10
antibody was purchased from Abcam (Cambridge, UK) and those
against histone H3, phospho-cAMP response element-binding protein
and cAMP response element-binding protein were obtained from Cell
Signaling Technology (Danvers, MA). VRK1 antibody was generated
in rabbit, and phospho-BAF antibody was a gift from Robert Craigie,
US National Institutes of Health. Hoechst 33342 stain and CNBr-
Sepharose 4B were purchased from Sigma-Aldrich.
Plant Material
C. sappan wood was purchased from an oriental drug store in
Pohang, Gyeongbuk, South Korea, in May 2010. A voucher specimen
(CS2010-01) is being kept at the Laboratory of Molecular Neurophys-
iology, Postech, Pohang, South Korea.
Extraction and Isolation. The dried wood of C. sappan (4.2 kg)
was extracted twice with ethyl acetate (EtOAc; 20 l) at room
temperature and filtered (Adventec filter paper no. 2; Adventec,
Ehime, Japan). The extract was obtained by concentration under
reduced pressure. The EtOAc extract (29.6 g) was subjected to
chromatography over silica gel (7.5  15 cm) and eluted with
a chloroform-methanol gradient (8:1, 6:1, and 3:1) to produce 10
fractions (CSE1–CSE10). Fraction CSE7 (1.25 g) was subjected to
silica gel column chromatography (4.5  14 cm) and eluted with
n-hexane-EtOAc (2:3, 1:2) to obtain compound 1 (125 mg).
Characterization of Brazilin. Brazilin was characterized by
comparing NMR spectrometry, MS, and IR spectrometry results with
literature values (Baek et al., 2000). Brazilin (7,11b-dihydroindeno
[2,1-c]chromene-3,6a,9,10(6H)-tetrol): pale-yellow crystals. IR (KBr,
cm21): 3378, 2915, 2850, 1615, 1510, 1465; electron ionization–MSm/z:
286[M]1, 268[M-H2O]1, 267[M-H-H2O]1, 229;
1H-NMR (500 MHz,
CD3OD, d): 7.20 (1H, d, J 5 8.5, H-1), 6.73 (1H, s, H-8), 6.62 (1H, s,
H-11), 6.49 (1H, dd, J5 8.5, 2.5 Hz, H-2), 6.32 (1H, d, J5 2.5 Hz, H-4),
3.99 (1H, br. second, H-12), 3.95 (1H, dd, J 5 11.0, 1.0 Hz, H-6a), 3.71
(1H, d, J5 11.0 Hz, H-6b), 3.04 (1H, d, J 5 15.5 Hz, H-7a), 2.79 (1H, d,
J 5 15.5 Hz, H-7b); 13C-NMR (125 MHz, CD3OD, d): 157.8 (C-49),
155.7 (C-3), 145.6 (C-9), 145.3 (C-10), 137.4 (C-119), 132.2 (C-1), 131.3
(C-79), 115.5 (C-19), 112.9 (C-8), 112.4 (C-11), 109.9 (C-2), 104.3 (C-4),
78.1 (C-69), 70.8 (C-6), 51.0 (C-12), 42.9 (C-7).
Plasmids, Recombinant Protein Purification. To generate
the BAF and VRK1 expression constructs, the full-length BAF and
VRK1 genes were amplified from HeLa cells using the polymerase
chain reaction. Each amplicon was cloned into phospho-enhanced
green fluorescent protein-C1, phospho-Discosoma fluorescent red
(DsRed)-Monomer-N1, and pProEX (Clontech, Takara Bio, Shiga,
Japan). To purify recombinant glutathione S-transferase-VRK1, His-
VRK1, and His-BAF, Escherichia coli strain BL21 was transformed
with pGEX-4T-3-VRK1, pProEX-VRK1, or pProEX-BAF and expressed
proteins were purified using Ni-NTA beads (Invitrogen/Life Technol-
ogies, Carlsbad, CA).
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Cell Culture and Transfection
The A549 and SH-SY5Y cells were cultured in RPMI 1640 and
Dulbecco’s modified Eagle’s medium–high-glucose media, respectively
(HyClone Laboratories, Logan, UT) containing 10% fetal bovine
serum (HyClone) and 1% penicillin/streptomycin (Welgene, Daegu,
South Korea) in a humidified 5% CO2 incubator at 37°C. Tran-
sient transfection was performed using an MP-100 microporator
(Invitrogen/Life Technologies), according to the manufacturer’s
instructions.
Terminal Deoxynucleotidyl Transferase–Mediated
Digoxigenin-Deoxyuridine Nick-End Labeling Assay
A549 cells were transfected with DsRed-N1-monomer-BAF or, in
the case of controls, not transfected. Cells were grown on glass chips
coated with poly-D-lysine (Sigma-Aldrich) and then treated with
brazilin (100 mM) for different times. Cells were fixed with 4%
paraformaldehyde, permeabilized, and stained with Hoechst stain
and the DeadEnd Fluorometric terminal deoxynucleotidyl
transferase–mediated digoxigenin-deoxyuridine nick-end labeling
(TUNEL) system kit (Promega, Madison, WI), according to the
manufacturer’s instructions.
Protein Kinase Assay and Immunoblotting
An in vitro kinase assay was performed in accordance withmethods
previously described elsewhere (Kim et al., 2013). In brief, an in vitro
kinase assay was performed with His-VRK1 and its substrates,
including His-BAF and His-H3 histone, in kinase buffer (50 mM 3-N-
morpholino)propanesulfonic acid, pH 7.2, 25 mM b-glycerophosphate,
10 mM EGTA, 4 mM EDTA, 50 mM MgCl, 0.5 mM dithiothreitol)
containing [g-32P]ATP (PerkinElmer) or ATP (Sigma-Aldrich). The
kinase assay mixtures were incubated at 30°C for 30 minutes.
Radioactivity incorporation was detected by autoradiography, and
phosphorylation of His-H3 histone was analyzed by immunoblotting.
The quantities of proteins used in kinase assays were measured by
using silver nitrate (Sigma-Aldrich) or immunoblotting. Immunoblot
analysis was performed as we previously described elsewhere (Park
et al., 2011). For immunoblot analysis, bands were visualized using
the Western blot detection kit (Neuronex, Pohang, South Korea).
Luteolin-Sepharose 4B Preparation and In Vitro Pull-Down
Assay
CNBr-sepharose 4B bead powder was suspended in activation
solution for coupling reaction. Activated Sepharose 4B beads were
incubated in coupling solution with brazilin on a rotary shaker at 4°C
overnight. For the in vitro pull down assay, His-BAF or A549 cell
lysates transfected with green fluorescent protein (GFP)-BAF were
incubated with brazilin-Sepharose 4B beads in reaction solution for
12 hours. Proteins bound to the beads were analyzed by immunoblot-
ting. Immnunoblotting was performed by using indicated antibodies
and following the detailed procedures described previously (Byun
et al., 2010).
Surface Plasmon Resonance
BAFwas immobilized on a carboxymethyl dextran hydrogel surface
sensor chip (Reichert Technologies, Depew, NY) using a 10 mM
sodium acetate, pH 5.0 immobilization buffer. The ligand was
prepared. Kinetic titration was performed using a running buffer of
10 mM phosphate-buffered saline (PBS), pH 7.4, 1% dimethylsulf-
oxide (DMSO). Analysis of the collected data were performed by
scrubber2 software (BioNavis, Tampere, Pirkanmaa, Finland).
Confocal Microscopy
A549 cells transfected with DsRed-N1-monomer-VRK1 or GFP-
BAF were grown on a chip, and then treated with 50 mM brazilin for
12 hours. Cells were fixed with paraformaldehyde, permeabilized in
PBS with 10% fetal bovine serum, and stained with Hoechst. Cells
were observed using confocal microscopy.
Immunocytochemistry
The A549 cells were grown on a chip and then treated with 50 mM
brazilin for 12 hours. Cells were fixed with paraformaldehyde
permeabilized in PBS with 10% fetal bovine serum, and stained with
lamin B antibody (Santa Cruz Biotechnology) and Hoechst. Cells were
observed using confocal microscopy. We calculated the cells to show
diffused lamin B in cytosol of HeLa cells. Data represent the mean of
three independent experiments 6 S.E.M. Each experiment has at
least three samples, and each sample had at least 50 cells.
Flow Cytometry
Cells were fixed with 70% ethanol containing 0.4% Tween 20.
Cellular DNA was stained with 50 mg/ml propidium iodide (Fluka,
Buchs, Switzerland) and 100 mg/ml RNase A (Sigma-Aldrich) in PBS.
Samples containing 5000 cells were analyzed using a FACS Calibur
System (BD Biosciences, Franklin Lakes, NJ).
Mouse Experiment
We randomly assigned 4-week-old athymic Balb/c nude male mice
weighing 20 g into the following groups: 20 and 40 mg/kg brazilin (n5
3 per group), and control (n 5 2). Each mouse was injected
subcutaneously with A549-FIG cells (5  106 cells/mouse). When
tumor size reached to ∼5 mm in diameter, mice were intratumorally
treated with 20 and 40 mg/kg brazilin, or 10% DMSO in PBS twice
a week. Treatment continued for 2 weeks. Tumor growth was
monitored using both in vivo bioluminescence imaging and tumor
volume measurement with caliper (length  width  height  0.52).
Bioluminescence imaging was performed using the IVIS Lumina II
(Caliper Life Sciences, Hopkinton, MA), which included a highly
sensitive charge-coupled device camera mounted on a light-tight
specimen chamber. The D-luciferin potassium salt (Caliper Life
Sciences) was diluted to 3 mg/100 ml in PBS before use, and the mice
were injected intraperitoneally with 100 ml of this D-luciferin solution.
After 10 minutes, the mice were placed individually in the specimen
chamber and then were measured with light emitted by luciferase.
Grayscale photographic images and bioluminescent color images
were superimposed using LIVINGIMAGE, version 2.12 (Xenogen,
Alameda, CA), and IGOR image analysis FX software (WaveMetrics,
Lake Oswego, OR). Bioluminescence signals were expressed in units
of photons per cm2 per second per steradian (P/cm2/s/sr). To quantify
emitted light, regions of interest were drawn over the tumor region,
and total photon effluxes over an exposure time of 1 second were
determined.
Results
Characterization of Brazilin from C. sappan. VRK1 is
the sole BAF kinase identified to date. As natural compounds
have long been used to develop new drugs, we screened
a library composed of hundreds of natural product extracts to
identify a small molecule inhibitor of VRK1-mediated BAF
phosphorylation (data not shown). A fraction isolated from
C. sappan L. significantly inhibited VRK1-mediated BAF
phosphorylation in vitro (data not shown). Thus, we hypoth-
esized it must contain an inhibitor of VRK1-mediated BAF
phosphorylation. Next, we attempted to isolate the putative
VRK1 inhibitor from C. sappan (Supplemental Fig. 1). NMR
spectrometry, MS, and IR spectrometry results indicated that
the compound isolated was brazilin (Fig. 1, A–C).
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Brazilin Inhibits VRK1-Mediated Phosphorylation of
BAF. To determine whether brazilin isolated from C. sappan
inhibits VRK1-mediated phosphorylation of BAF, we per-
formed an in vitro kinase assay using purified BAF and
VRK1. Administration of between 3 and 10 mM of brazilin
dramatically reduced BAF phosphorylation. The half maxi-
mal inhibitory concentration (IC50) was estimated to be
approximately 5 mM (Fig. 2A). This indicates that C. sappan
brazilin is an effective inhibitor of VRK1-mediated BAF
phosphorylation in vitro. By contrast, brazilin had no effect on
VRK1 autophosphorylation (Fig. 2A). This indicates that
brazilin does not directly inhibit VRK1 and is instead
a specific inhibitor of VRK1-mediated BAF phosphorylation.
Additionally, we found that brazilin did not affect VRK1-
mediated H3 phosphorylation (Fig. 2B; Supplemental Fig. 2).
These data indicate that C. sappan brazilin specifically
inhibits BAF in vitro.
Endogenous and ectopic VRK1 expression is localized in
the nucleus (Lopez-Borges and Lazo, 2000; Nichols and
Traktman, 2004; Sevilla et al., 2004a,b), as is ectopic BAF
expression (Segura-Totten et al., 2002; Shimi et al., 2004).
However, ectopic BAF expression can be transiently relocal-
ized into the cytosol when VRK1 is coexpressed with BAF
(Nichols et al., 2006). Relocation of BAF into the cytosol does
not occur 1) when VRK1 is coexpressed with a BAF mutant
that cannot be phosphorylated or 2) when a VRK1 catalytic
null mutant is coexpressed with ectopic BAF (Nichols et al.,
2006). These results indicate that VRK1-mediated BAF
phosphorylation determines the location of ectopically ex-
pressed BAF. Thus, by observing the location of ectopically
expressed BAF, we could infer whether VRK1-mediated BAF
phosphorylation occurred.
We used brazilin to treat cells in which DsRed-VRK1 was
coexpressed with GFP-BAF. Rather than being found in the
cytosol, GFP-BAF was located in the nucleus (Fig. 2C;
Supplemental Fig. 3A). The nuclear location of BAF in cells
treated with brazilin indicates that VRK1-mediated BAF
phosphorylation did not occur (Fig. 2C, bottom). Treatment
with DMSO resulted in the relocation of BAF into the cytosol,
indicating that GFP-BAF was phosphorylated by ectopically
expressed VRK1 under these conditions. To confirm the
inhibition of BAF phosphorylation by brazilin, we performed
an immunoblotting assay. Brazilin treatment expectably
reduced BAF phosphorylation in A549 cells (Supplemental
Fig. 3B). These data show that brazilin inhibits VRK1-
mediated BAF phosphorylation, supporting brazilin as a can-
didate inhibitor of BAF phosphorylation.
Brazilin Binds Specifically to BAF. To be an effective
BAF phosphorylation inhibitor, brazilin should bind specifi-
cally to BAF. Therefore we investigated whether brazilin
interacts directly with BAF. First, we performed a pull-down
assay to demonstrate binding between BAF and VRK1 in
vitro. Sepharose-4B beads were conjugated to the hydroxyl-
group of brazilin, and the brazilin-conjugated beads were
incubated with lysate of cells that overexpressed BAF.
Control beads that were not conjugated to brazilin did not
interact with BAF, and brazilin-conjugated beads bound to
GFP-BAF but not to GFP (Fig. 3A). This suggests that brazilin
formed a complex with the BAF present in the cell lysate.
However, as other proteins in the cell lysate could also
potentially form a complex with BAF, it was possible that the
BAF-brazilin interaction resulted from indirect binding. To
exclude this possibility, we conducted another pull-down
assay using recombinant BAF (Fig. 3B). When recombinant
BAF was incubated with brazilin-conjugated beads, BAF was
pulled down; however, no BAF was detected in association
with control beads. This suggests that brazilin interacts
directly with recombinant BAF.
Next, we measured the strength of the interaction between
brazilin and BAF using surface plasmon resonance (Fig. 3C).
We immobilized recombinant BAF on the surface of a gold
chip, and then allowed brazilin to flow over the chip, from low
to high concentration. This kinetic titration method can
perform as robustly as the classic injection method (Karlsson
Fig. 1. Brazilin was isolated from C. sappan. (A) Brazilin [1H]NMR and
[13C]NMR data. (B) Brazilin MS data. (C) Chemical structure of brazilin.
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et al., 2006). During the flow period, the intensity of the
interaction between brazilin and BAF was assessed via signal
alterations. The dissociation constant (KD) was 38.35 mM,
suggesting a good affinity between BAF and brazilin (Table 1).
Brazilin Disrupts Nuclear Envelope Reassembly by
Inhibiting BAF Phosphorylation. BAF phosphorylation
is a prerequisite for nuclear envelope reassembly during
telophase (Haraguchi et al., 2008). Phosphorylation of BAF
leads to its localization at the core region of the dividing
chromosome, inducing the recruitment of other nuclear
envelope-associated proteins, including LEM-domain pro-
teins, lamin, and nuclear pore complex. To determine
whether brazilin perturbs recruitment of nuclear envelope-
associated proteins by blocking VRK1-mediated BAF phos-
phorylation, we employed immunocytochemistry to observe
the location of lamin during telophase. In cells treated with
brazilin, lamin dispersed outside the nucleus, whereas in
control cells it was located around the rim of the nucleus, as
previously reported (Fig. 4A). The number of cells with lamin
localization defects was 6-fold higher in brazilin-treated cells
relative to control cells (Fig. 4B). These data show that control
cells progress normally from M phase to interphase, whereas
nuclear envelope reformation is disrupted in brazilin-treated
cells. Similarly, in siRNA-vrk-1C. elegans embryos, the nuclear
rim signals mAb414 and Nup96 disappear from the nuclear
periphery (Gorjanacz et al., 2007).
Because nuclear envelope reformation is a final step in
mitosis, failure of the nuclear envelope to reassemble could
delay mitotic exit. To determine whether brazilin-mediated
inhibition of lamin reformation delays mitotic progression,
we observed the cell cycle distribution of A549 cells using
flow cytometry. Treatment with brazilin increased the
proportion of G2/M cells 1.5-fold relative to control cells
(Fig. 4, C and D).
G2/M arrest induced by brazilin in multiple myeloma U266
cells has also been observed (Kim et al., 2012). These results
imply that brazilin-induced disruption of lamin localization
perturbs normal cell cycle progression. In particular, brazilin
disrupts recruitment of lamin to the anaphase chromatin
surface, delaying mitotic progression.
Fig. 2. Brazilin suppresses VRK1-mediated BAF phosphorylation in vitro and in vivo. (A) In vitro kinase assay in which VRK1 and BAFwere exposed to
increasing concentrations of brazilin (0.0, 0.3, 1.0, 3.0, 10, 30, 100, and 300 mM). (B) In vitro kinase assay in which VRK1 and H3 were exposed to
increasing concentrations of brazilin (0.0, 3.0, 10, and 30 mM). Autoradiograph was performed and the proteins were silver stained (A and B). (C) Images
of A549 cells treated with brazilin or DMSO. Cells were transfected with GFP-BAF or DsRed-VRK1 and stained with Hoechst. Images were acquired
using confocal microscopy. Scale bars, 40 mm. RFP, red fluorescent protein.
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Brazilin Possesses Cytotoxicity by Inhibiting BAF
Phosphorylation. A number of anticancer drugs induce
mitotic arrest by activating cell cycle checkpoints, leading
to cell death unless the checkpoint problems are resolved.
A limitation of this protective mechanism is that cancer cells
that undergo mitotic arrest can also escape via adaptation or
slippage. We hypothesized that targeting mitotic exit could
represent a novel strategy for overcoming this limitation, as
a result of higher cytotoxicity and the failure to generate
aneuploid cells. Thus, we tested whether brazilin induces cell
death.
To examine the cytotoxicity of brazilin we performed
a TUNEL assay with A549 cells. Brazilin treatment dramat-
ically decreased cell numbers and appeared to promote
growth retardation as well as cell death (Fig. 5A). Addition-
ally, we monitored cell growth using live, long-term content
imaging. When 25 mM brazilin was administered to 60%
confluent cells, the number of cells no longer increased, and
then the density decreased. These data indicate that brazilin
concentrations greater than 25 mM induce growth retarda-
tion, followed by cell death (Fig. 5B).
Asmentioned above, brazilin-induced cell death is triggered
after anaphase, when cell cycle checkpoint activation may not
lead to mitotic arrest. We hypothesized that the cell death
avoidance processes, such as adaptation and slippage, which
result from other microtubule inhibitors, would not occur in
response to brazilin. To test this hypothesis, we used flow
cytometry to study these processes.
As expected, both brazilin and nocodazole, a microtubule
inhibitor, induced cell death. However, when gating was used
to select live cells, it became evident that nocodazole
treatment increased the aneuploid cell population, indicating
that mitotic slippage and adaptation were triggered after cell
cycle arrest (Weaver and Cleveland, 2005). By contrast,
brazilin treatment did not generate aneuploid cells, indicating
that adaptation and slippage were not triggered (Fig. 5C).
These observations demonstrate that brazilin is cytotoxic to
cancer cells and does not allow adaptation or slippage. The
data support the idea that, rather than targeting micro-
tubules or microtubule regulating proteins, targeting mitotic
exit could represent a novel approach to cancer treatment that
is attractive because it does not generate aneuploid cells.
We hypothesized that if brazilin is directly involved in
inducing cell death by targeting BAF, ectopic expression of
DsRed-BAF should rescue brazilin-induced cytotoxicity. Indeed,
the results of the TUNEL assay showed that ectopically
expressed BAF reduced brazilin-induced cell death (Fig. 5D).
Thus, brazilin could induce cell death directly by targeting BAF.
Finally, we examined the anticancer effects of brazilin in
a mouse model. We generated an A549-FIG cell line infected
with lenti-Fluc-IRES-GFP; cell numbers were calculated by
measuring fluorescence intensity (Supplemental Fig. 4A). The
A549-FIG cells appeared to have proliferative abilities similar
to those of normal A549 cells (Supplemental Fig. 4B),
indicating that lenti-Fluc-IRES-GFP did not impair cell
growth and reproduction. These cells were implanted on the
ventral aspect of the mouse. Tumor volume increased in
control mice but decreased in mice treated with brazilin in
a concentration-dependent manner, suggesting that brazilin
has anticancer effect in vivo (Fig. 5, E and F).
Discussion
We hypothesized that targeting BAF, and particularly
VRK1-mediated BAF phosphorylation, would have several
Fig. 3. Brazilin binds specifically to BAF. (A) BAF pull-down assay using
brazilin-conjugated Sepharose-4B beads. A549 cells were transfected with
GFP-Mock or GFP-BAF. Cell lysates were incubated with brazilin-conjugated
beads or control bead. Western blotting was performed with glyceraldehyde
3-phosphate dehydrogenase (GAPDH) as the loading control. (B) Binding
assay in which recombinant His-BAFwas incubated with the same beads and
a Western blot analysis was performed. (C) Surface plasmon resonance was
performed on brazilin and recombinant His-BAF. IB, immunoblotting.
TABLE 1
Kinetic parameters of the binding of brazilin to BAF
Ka Kd KD
M21S21 S21 mM
BAF/brazilin 4.873 1.869e24 38.35
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benefits over targeting other mitotic kinases or microtubules.
To test our hypothesis, we attempted to identify a specific
inhibitor of BAF phosphorylation. We screened a library of
natural compounds and isolated brazilin, a BAF inhibitor
from C. sappan. We confirmed that brazilin isolated from
C. sappan inhibits VRK1-mediated BAF phosphorylation in
vitro and in vivo. In addition, we determined that brazilin-
induced BAF inhibition blocks nuclear envelope reformation
during telophase, inducing cell death in cancer cells.
Brazilin has several merits as an anticancer drug. First,
BAF is an excellent target compared with other cancer drug
targets, such as microtubules or microtubule regulatory
proteins. Despite reliable anticancer activity, microtubule
inhibitors have severe side effects. And contrary to expectation,
at tolerable concentrations, microtubule regulatory protein
inhibitors investigated as a substitute for microtubule blockers
have displayed weak anticancer effects (Komlodi-Pasztor et al.,
2012; Mitchison, 2012).
We and other researchers expected that mitotic exit might
represent an alternative target, because it would not allow
cancer cells to survive via mitotic slippage or adaptation. An
example in support of this hypothesis is that tumor regression
is greater in response to a treatment ablating Cdc20, which
activates anaphase promoting complex, than in response to
othermitotic drugs currently used in cancer therapy (Manchado
et al., 2010).
We selected brazilin, a BAF inhibitor, to target the end of
mitosis. BAF plays a role in recruiting nuclear envelope-
associated proteins, including lamin, emerin, MAN1, and
LAP2, to the chromosomal core region (Haraguchi et al.,
Fig. 4. Suppression of BAF phosphorylation disrupts nuclear envelope assembly. (A) Immunocytochemical staining in HeLa cells after treatment with
brazilin 50 mM or DMSO. Nucleus was stained with Hoechst stain and lamin B antibody. Scale bars, 20 mm. (B) Quantification of failed nuclear envelope
reassembly in cells described in (A). Data in (B) represent the mean of three independent experiments 6 S.E.M. P values were calculated using two-
tailed, paired Student’s t tests. ***P, 0.0005. (C) Flow cytometric analysis of A549 cells treated with brazilin 100 mM or DMSO. DNA was stained using
propidium iodide. (D) Quantification of the proportion of cells in (C) in the G2/M stage.
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2008), supporting nuclear envelope reformation atmitotic exit
(Haraguchi et al., 2001; Molitor and Traktman, 2014). Phos-
phorylation by VRK1, a novel BAF kinase, determines BAF
localization during nuclear envelope reassembly (Haraguchi
et al., 2008;Molitor and Traktman, 2014). Therefore, inhibition
of VRK1-mediated BAF phosphorylation deserves attention in
the field of cancer treatment.
Recently, it was reported that aberrant alterations of
nuclear envelope components, including lamin, emerin,
LAP2, and nucleoporin, are connected to cancer development
(Chow et al., 2012). Cancer cells often have altered nuclear
structures, including nuclear envelope invaginations and
multilobulation; in fact, these features are used in the clinical
diagnosis of cancers (Fischer et al., 2004; Bussolati, 2008;
Bussolati et al., 2008; Petersen et al., 2009; Gorjanacz, 2014).
Cancer cells are so susceptible to nuclear envelope alterations
that drugs that disturb nuclear envelope distribution or
reformation could easily induce cell death. Therefore, a treat-
ment that weakens the nuclear envelope might display
synthetic lethality (Gorjanacz, 2014). As BAF supports
nuclear envelope structures, the depletion or altered expres-
sion of BAF results in nuclear envelope alterations (Molitor
and Traktman, 2014). Therefore, targeting BAF could trigger
synthetic lethality by destroying the weak nuclear envelope of
cancer cells. Because depletion of VRK1 disrupts nuclear
envelope morphology—consistent with the BAF mutation
Fig. 5. Brazilin triggers cell death by suppressing BAF phosphorylation. (A) Quantification of TUNEL-positive cells in A549 cells treated with brazilin
100 mM or DMSO. Fixed cells were incubated with terminal deoxynucleotidyl transferase and Hoechst stain. Data in (A) are the mean of three
independent experiments6 S.E.M. P values were calculated using two-tailed, paired Student’s t tests. *P, 0.05; ***P, 0.0005. (B) Time lapse images
of a live cell using IncuCyte software (Essen BioScience, Ann Arbor, MI). (C) Flow cytometric analysis of HeLa cells treated with nocodazole 50 ng/ml or
brazilin 100 mM. DNAwas stained using propidium iodide, and DNA content in live cells was analyzed. (D) Quantification of TUNEL-positive A549 cells
transfected with DsRed-BAF or DsRed-Mock. These cells were treated with or without brazilin 100 mM. Data in (D) are the mean of three independent
experiments 6 S.E.M. P values were calculated using two-tailed, paired Student’s t tests. ***P , 0.0005. (E) Mouse tumor size, recorded using in vivo
live imaging, and (F) quantification of the size of the mouse tumors.
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phenotype (Molitor and Traktman, 2014)—targeting VRK1
may induce synthetic lethality as well.
For these reasons, several researchers have considered the
possibility of developing BAF phosphorylation inhibitors as
anticancer drugs (Gorjanacz, 2014). We have reported that
Obtusilactone B, an inhibitor of BAF phosphorylation,
perturbs detachment of chromosomes from the nuclear
envelope at S phase and M phase entry, thus displaying
anticancer activity (Kim et al., 2013). However, treatment
with Obtusilactone B did not result in obstruction of telo-
phase, which would be more effective. In this article, we
propose that blocking mitotic exit via brazilin-induced BAF
inhibition may be a good target that results in cancer cell
death.
The mechanism by which brazilin binds specifically to BAF
and impairs only telophase progression, but not S phase,
remains elusive. Brazilin may directly bind the Thr-2, Thr-3,
and Ser-4 residues of BAF, which are known VRK1-mediated
BAF phosphorylation sites, or may act as an allosteric
inhibitor of BAF by binding another site. Structure-based
analysis should be performed to identify the mechanism by
which brazilin inhibits BAF.
In addition, we note that brazilin could induce nuclear
envelope disturbance in normal cells as well as cancer cells.
Brazilin-induced disruption of nuclear envelope structures is
similar to features observed in patients with progeria. In fact,
a homozygous mutation in BANF1, the gene encoding BAF,
has been detected in atypical progeria patients; the mutation
reduces BAF stability, impairing nuclear envelope structure
(Puente et al., 2011). Brazilin may accelerate aging by
interfering with the nuclear envelope reassembly of normal
cells. However, the probability of this occurring during cancer
treatment may not be significant because in progeria the
early-aging phenotype progresses over a long time period
(Gorjanacz, 2014).
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